Scinovex
articleTop 10% cited

Challenges in the development of high protein concentration formulations

Journal of Pharmaceutical Sciences · 2004 · Vol. 93(6) · pp. 1390–1402
Steven J. ShireZahra ShahrokhJun 军 Liu 刘
Protein purification and stabilityAdvanced Drug Delivery SystemsDrug Solubulity and Delivery SystemsSolubilityChemistryDilutionProtein stabilityHigh proteinProtein aggregationChromatographySize-exclusion chromatographyBiochemistryOrganic chemistry

MeSH terms

AnimalsChemistry, PharmaceuticalHumansProteinsSolubilityTechnology, Pharmaceutical
Citations
861
FWCI
5.52
field-weighted impact
References
58
Percentile
97%
vs. same field & year
Citations per year
Cited by
Aggregates in monoclonal antibody manufacturing processes
Biotechnology and Bioengineering · 2011 · 473 citations
Effects of glycosylation on the stability of protein pharmaceuticals
Journal of Pharmaceutical Sciences · 2008 · 636 citations
Protein aggregation: Pathways, induction factors and analysis
Journal of Pharmaceutical Sciences · 2008 · 879 citations
Antibody Structure, Instability, and Formulation
Journal of Pharmaceutical Sciences · 2006 · 923 citations
Related articles
Challenges in the development of high protein concentration formulations
Journal of Pharmaceutical Sciences · 2004 · 861 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Challenges in the development of high protein concentration formulations · Scinovex